ROTHSCHILD INVESTMENT LLC /IL - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 179 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROTHSCHILD INVESTMENT LLC /IL ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$95
+13.1%
29,850
+76.1%
0.01%
+14.3%
Q2 2023$840.0%16,9500.0%0.01%0.0%
Q1 2023$84
-21.5%
16,9500.0%0.01%
-30.0%
Q4 2022$107
-99.9%
16,950
+61.4%
0.01%
-9.1%
Q3 2022$113,000
-8.1%
10,500
-2.8%
0.01%0.0%
Q2 2022$123,000
+25.5%
10,8000.0%0.01%
+37.5%
Q1 2022$98,000
-39.1%
10,8000.0%0.01%
-33.3%
Q4 2021$161,000
-51.1%
10,800
-15.6%
0.01%
-57.1%
Q3 2021$329,00012,8000.03%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
VV Manager LLC 1,798,163$76,997,00067.53%
Wildcat Capital Management, LLC 1,515,524$64,895,00022.42%
TPG Group Holdings (SBS) Advisors, Inc. 19,716,306$844,252,00014.91%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 1,279,281$54,779,0007.69%
Coastal Bridge Advisors, LLC 463,117$19,831,0006.33%
DSAM Partners (London) Ltd 235,098$10,067,0002.63%
Casdin Capital, LLC 625,000$26,763,0001.58%
Alpine Global Management, LLC 150,000$6,423,0001.13%
Perceptive Advisors 1,543,790$66,105,0001.07%
Avoro Capital Advisors LLC 1,128,594$48,326,0000.96%
View complete list of ALLOGENE THERAPEUTICS INC shareholders